Search Results - "Lowder, Careen"

The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases by Pichi, Francesco, Sarraf, David, Arepalli, Sruthi, Lowder, Careen Y., Cunningham, Emmett T., Neri, Piergiorgio, Albini, Thomas A., Gupta, Vishali, Baynes, Kimberly, Srivastava, Sunil K.

“…Since its introduction in the early 1990s, optical coherence tomography (OCT) has evolved in resolution and technological advances, and in recent years its…”
Get full text

Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography by Sharma, Sumit, MD, Lowder, Careen Y., MD, PhD, Vasanji, Amit, PhD, Baynes, Kimberly, COA, Kaiser, Peter K., MD, Srivastava, Sunil K., MD

“…Purpose This study was designed to determine the feasibility of anterior segment optical coherence tomography (AS-OCT) to objectively image and quantify the…”
Get full text

Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis by Levison, Ashleigh L, Baynes, Kimberly M, Lowder, Careen Y, Kaiser, Peter K, Srivastava, Sunil K

“…To describe the findings seen on optical coherence tomography angiography (OCTA) in patients with punctate inner choroidopathy (PIC) and multifocal choroiditis…”
Get more information

Anterior chamber cell grading by optical coherence tomography by Li, Yan, Lowder, Careen, Zhang, Xinbo, Huang, David

“…To quantify cells in the ocular anterior chamber (AC) by optical coherence tomography (OCT). A time-domain anterior segment OCT system was used to image latex…”
Get full text

Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy using a Modified Delphi Approach by Fox, Austin R, Gordon, Lynn K, Heckenlively, John R, Davis, Janet L, Goldstein, Debra A, Lowder, Careen Y, Nussenblatt, Robert B, Butler, Nicholas J, Dalal, Monica, Jayasundera, Thiran, Smith, Wendy M, Lee, Richard W, Adamus, Grazyna, Chan, Chi-Chao, Hooks, John J, Morgans, Catherine W, Detrick, Barbara, Sen, H. Nida

“…Abstract Purpose To develop diagnostic criteria for nonparaneoplastic autoimmune retinopathy (AIR) through expert panel consensus and to examine treatment…”
Get full text

EN FACE OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MULTIPLE EVANESCENT WHITE DOT SYNDROME: New Insights Into Pathogenesis by Pichi, Francesco, Srvivastava, Sunil K, Chexal, Saradha, Lembo, Andrea, Lima, Luiz H, Neri, Piergiorgio, Saitta, Andrea, Chhablani, Jay, Albini, Thomas A, Nucci, Paolo, Freund, K Bailey, Chung, Hyewon, Lowder, Careen Y, Sarraf, David

“…To localize the various levels of abnormalities in multiple evanescent white dot syndrome by comparing "en face" optical coherence tomography (OCT) and OCT…”
Get full text

Switching from intravenous to subcutaneous tocilizumab for uveitis during the COVID-19 pandemic: a case series by Mohan, Nitesh, Srivastava, Sunil K., Baynes, Kimberly, Lowder, Careen Y., Sharma, Sumit

Get full text

ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA by Lavine, Jeremy A, Singh, Arun D, Sharma, Sumit, Baynes, Kimberly, Lowder, Careen Y, Srivastava, Sunil K

“…To determine the features of primary vitreoretinal lymphoma on multimodal ultra-widefield imaging and correlate these findings to clinical outcomes. We report…”
Get full text

EN FACE OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MULTIPLE EVANESCENT WHITE DOT SYNDROME: New Insights Into Pathogenesis by Pichi, Francesco, Srvivastava, Sunil K, Chexal, Saradha, Lembo, Andrea, Lima, Luiz H, Neri, Piergiorgio, Saitta, Andrea, Chhablani, Jay, Albini, Thomas A, Nucci, Paolo, Freund, K Bailey, Chung, Hyewon, Lowder, Careen Y, Sarraf, David

“…To localize the various levels of abnormalities in multiple evanescent white dot syndrome by comparing "en face" optical coherence tomography (OCT) and OCT…”
Get full text

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial by Suhler, Eric B, Lowder, Careen Y, Goldstein, Debra A, Giles, Tracy, Lauer, Andreas K, Kurz, Paul A, Pasadhika, Sirichai, Lee, Shelly T, de Saint Sardos, Alexandre, Butler, Nicholas J, Tessler, Howard H, Smith, Justine R, Rosenbaum, James T

“…Tumour necrosis factor (TNF) blockers have been demonstrated to be effective in the treatment of systemic and ocular inflammatory diseases. We conducted a…”
Get more information

PERIPHERAL RETINOSCHISIS IN INTERMEDIATE UVEITIS by Pichi, Francesco, Srivastava, Sunil K, Nucci, Paolo, Baynes, Kimberly, Neri, Piergiorgio, Lowder, Careen Y

“…To examine cases of intermediate uveitis complicated by retinoschisis and review the pathogenetic hypothesis. A retrospective chart review of patients with…”
Get full text

Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis by Ganapathy, Preethi S., Lowder, Careen Y., Arepalli, Sruthi, Baynes, Kimberly, Li, Manshi, Bena, James, Srivastava, Sunil K.

“…Noninfectious uveitis has been treated historically with corticosteroid therapy in varying doses and routes. Triesence, a preservative-free sterile formulation…”
Get full text

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation by Galor, Anat, Perez, Victor L, Hammel, Jeffrey P, Lowder, Careen Y

“…Anti-tumor necrosis factor alpha (anti-TNF-alpha) agents are being used increasingly in refractory inflammatory eye diseases. We reviewed our patients on…”
Get more information

Recurrence Rates of Inflammation after Switching from the Originator Infliximab to Biosimilar Infliximab-abda for Noninfectious Uveitis by Deaner, Jordan D., Srivastava, Sunil K., Hajj-Ali, Rula A., Lowder, Careen Y., Venkat, Arthi G., Baynes, Kimberly, Sharma, Sumit

“…To describe the frequency of ocular flares in patients with noninfectious uveitis who were switched from the originator infliximab to a biosimilar infliximab…”
Get full text

Foscarnet eyedrops for the treatment of refractory herpetic keratitis by Awh, Caroline C., Knapp, Austen N., Goshe, Jeffrey M., See, Craig W., Lowder, Careen Y.

“…Purpose The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic…”
Get full text

Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants by Cao, Jessica L., Srivastava, Sunil K., Lowder, Careen Y., Sharma, Sumit, Baynes, Kimberly, Eisengart, Jonathan

“…PRECIS:In eyes with uveitis and a history of fluocinolone acetonide (FA) implantation, glaucoma drainage implants (GDIs) provides excellent long-term control…”
Get full text

A United States expert consensus to standardise definitions, follow‐up, and treatment targets for extra‐intestinal manifestations in inflammatory bowel disease by Falloon, Katherine, Cohen, Benjamin, Ananthakrishnan, Ashwin N., Barnes, Edward L., Bhattacharya, Abhik, Colombel, Jean‐Frederic, Cross, Raymond K., Driscoll, Marcia S., Fernandez, Anthony P., Ha, Christina, Herfarth, Hans, Horst, Sara, Hou, Jason, Husni, M. Elaine, Kroshinsky, Daniela, Kuhn, Kristine A., Lowder, Careen Y., Martin, George, Parikh, Deep, Sayed, Christopher J., Schocket, Lisa, Siaton, Bernadette C., Vedak, Priyanka, Weisman, Michael H., Rieder, Florian

“…Summary Background and aims Extra‐intestinal manifestations (EIMs) are a common complication of inflammatory bowel diseases (IBD), affecting up to half of the…”
Get full text

RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE by Feiler, Daniel L, Srivastava, Sunil K, Pichi, Francesco, Bena, James, Lowder, Careen Y

“…To evaluate the short-term safety and efficacy of topical difluprednate (0.05%) for the treatment of noninfectious uveitic cystoid macular edema. Twenty-seven…”
Get full text

Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series by Hamdan, Abel, Sharma, Sumit, Baynes, Kimberly, Hajj Ali, Rula A., Lowder, Careen Y., Srivastava, Sunil K.

“…Background/Aims Anti-tumor necrosis factor (Anti-TNF) agents have proven beneficial for the treatment of chronic non-infectious uveitis, yet rare neurological…”
Get full text

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality by Kempen, John H, Newcomb, Craig W, Washington, Terri L, Foster, C Stephen, Sobrin, Lucia, Thorne, Jennifer E, Jabs, Douglas A, Suhler, Eric B, Rosenbaum, James T, Sen, H Nida, Levy-Clarke, Grace A, Nussenblatt, Robert B, Bhatt, Nirali P, Lowder, Careen Y, Goldstein, Debra A, Leiderman, Yannek I, Acharya, Nisha R, Holland, Gary N, Read, Russell W, Dunn, James P, Dreger, Kurt A, Artornsombudh, Pichaporn, Begum, Hosne A, Fitzgerald, Tonetta D, Kothari, Srishti, Payal, Abhishek R, Daniel, Ebenezer, Gangaputra, Sapna S, Kaçmaz, R Oktay, Liesegang, Teresa L, Pujari, Siddharth S, Khachatryan, Naira, Maghsoudlou, Armin, Suga, Hilkiah K, Pak, Clara M, Helzlsouer, Kathy J, Buchanich, Jeanine M

“…To determine the incidence of all-cause and cancer mortality (CM) in association with immunosuppression. Retrospective cohort study at ocular inflammatory…”
Get full text